Global Minimally Invasive Surgery Market (2010 - 2015)

101 64
Original Source: Invasive Surgery Market

Buy Now: Market Research

The technology shift from invasive to minimally invasive surgery (MIS) has brought about significant changes in the field of medicine. MIS techniques improve surgical outcomes, reduce associated risks, and also minimize the time required for post-operative recovery and hospitalization. These factors have led a rapid growth of MIS procedures over open surgeries. While minimally invasive cosmetic surgeries are witnessing growth due to the rising levels of health- and beauty-consciousness, and minimally invasive cardiac surgery offers greater safety and cost-effectiveness than invasive techniques.

However, the high initial investments for MIS devices form a significant cause for concern. This is the case even in developed markets such as the U.S., where healthcare reforms are expected to reduce Medicare and Medicaid payments to hospitals. This is expected to reduce hospital expenditure on medical equipment. In addition to the comprehensive information on the macro-markets, this report gives a detailed analysis of critical micro-markets, which have so far remained unexplored.

Table of Contents

Executive Summary

Market Scenario

Emerging Mis Techniques

1 Introduction

1.1 Key Take Aways

1.2 Report Description

1.3 Markets Covered

1.4 Research Methodology

1.5 Stakeholders

2 Summary

3 Market Overview

3.1 Introduction

3.2 Market Segmentation

3.2.1 Product Market Share Analysis

3.2.2 End-user Analysis

3.3 Competitive Landscape

3.4 Factors Influencing Market Growth

3.4.1 Supply-side Drivers

3.4.2 Demand-side Drivers

3.4.3 Threats

3.4.4 Opportunities

3.5 Future Developments

3.5.1 Information Technologies For Mis

3.5.2 New Concepts

3.5.3 Micro- & Nano-robotics In Medicine.

3.6 Patent Growth Analysis

4 Mis Products & Technologies Market

4.1 Mis Products Market

4.1.1 Factors Influencing Market Growth

4.1.1.1 Technology Developments Increase Mis Penetration In Other Surgical Sub-specialties

4.1.1.2 High Cost Of Mis Devices

4.1.2 Endoscopic Devices

4.1.3 Electrosurgical Devices

4.1.4 Monitoring & Visualization Devices

4.1.5 Cryosurgical Unit

4.1.6 Imaging Technologies

4.1.7 Other Mis Equipment

4.2 Mis Technology Market

5 Mis Applications Markets

5.1 Introduction

5.1.1 Factors Influencing Market Growth

5.1.1.1 Increasing Age And Failing Health

5.1.1.2 Rise In Chronic Diseases Due To Changing Lifestyle

5.1.1.3 Training Initiatives By Oems For Medics

5.1.1.4 Demand For Patient-friendly Operating Methods

5.1.1.5 Risk Of Postoperative Infections Due To Reprocessed Single-use Devices (Suds)

5.2 Cosmetic Surgery

5.3 Breast Surgery

5.4 Obesity Surgery

5.5 Cardiac Surgery

5.6 Gastrointestinal Surgery

5.7 Orthopedic Surgery

5.7.1 Spinal Surgery

5.7.2 Joint Replacement

5.8 Laparoscopic Surgery

5.9 Cryosurgery/Cryoablation

6 Geographic Analysis

6.1 Introduction

6.2 U.S. Mis Market

6.3 Europe Mis Market

6.4 Apac Mis Market

6.5 Row Mis Market

7 Competitive Landscape

8 Company Profiles

8.1 Abbott Laboratories

8.1.1 Overview

8.1.2 Primary Business

8.1.3 Strategy

8.1.4 Developments

8.2 Aesculap Inc

8.2.1 Overview

8.2.2 Primary Business

8.2.3 Strategy

8.2.4 Developments

8.3 Alphatec Spine Inc

8.3.1 Overview

8.3.2 Primary Business

8.3.3 Strategy

8.3.4 Developments

8.4 Arthrocare Corp

8.4.1 Overview

8.4.2 Primary Business

8.4.3 Strategy

8.4.4 Developments

8.5 Atricure Inc

8.5.1 Overview

8.5.2 Primary Business

8.5.3 Developments

8.6 Biomet Inc

8.6.1 Overview

8.6.2 Primary Business

8.6.3 Strategy

8.7 Boston Scientific Corporation

8.7.1 Overview

8.7.2 Primary Business

8.7.3 Strategy

8.7.4 Developments

8.8 Charles Russell Bard Inc

8.8.1 Overview

8.8.2 Primary Business

8.8.3 Strategy

8.8.4 Developments

8.9 Conmed Corporation

8.9.1 Overview

8.9.2 Primary Business

8.9.3 Strategy

8.1 Cooper Surgical Inc

8.10.1 Overview

8.10.2 Primary Business

8.10.3 Strategy

8.10.4 Developments

8.11 Covidien

8.11.1 Overview

8.11.2 Primary Business

8.11.3 Strategy

8.11.4 Developments

8.12 Depuy Spine Inc

8.12.1 Overview

8.12.2 Primary Business

8.12.3 Strategy

8.12.4 Developments

8.13 Ethicon Endo-surgery Inc

8.13.1 Overview

8.13.2 Primary Business

8.13.3 Strategy

8.13.4 Developments

8.14 Fujifilm Holdings Corporation

8.14.1 Overview

8.14.2 Primary Business

8.14.3 Strategy

8.14.4 Developments

8.15 Ge Healthcare

8.15.1 Overview

8.15.2 Primary Business

8.15.3 Strategy

8.15.4 Developments

8.16 Given Imaging Ltd.

8.16.1 Overview

8.16.2 Primary Business

8.16.3 Strategy

8.16.4 Developments

8.17 Hansen Medical

8.17.1 Overview

8.17.2 Primary Business

8.17.3 Strategy

8.17.4 Developments

8.18 Hitachi Medical Corporation

8.18.1 Overview

8.18.2 Primary Business

8.18.3 Strategy

8.18.4 Developments

8.19 Integra Lifesciences Holdings Corp

8.19.1 Overview

8.19.2 Primary Business

8.19.3 Strategy

8.19.4 Developments

8.2 Intuitive Surgical Inc

8.20.1 Overview

8.20.2 Primary Business

8.20.3 Strategy

8.20.4 Developments

8.21 K2m Inc

8.21.1 Overview

8.21.2 Primary Business

8.21.3 Strategy

8.21.4 Developments

8.22 Karl Storz Endoscope Berlin Gmbh

8.22.1 Overview

8.22.2 Primary Business

8.22.3 Strategy

8.22.4 Developments

8.23 Medtronic Inc

8.23.1 Overview

8.23.2 Primary Business

8.23.3 Strategy

8.23.4 Developments

8.24 Nuvasive Inc

8.24.1 Overview

8.24.2 Primary Business

8.24.3 Strategy

8.24.4 Developments

8.25 Olympus Corporation

8.25.1 Overview

8.25.2 Primary Business

8.25.3 Strategy

8.25.4 Developments

8.26 Pentax Medical Company

8.26.1 Overview

8.26.2 Primary Business

8.26.3 Strategy

8.26.4 Developments

8.27 Philips Healthcare

8.27.1 Overview

8.27.2 Primary Business

8.27.3 Strategy

8.27.4 Developments

8.28 Siemens Healthcare

8.28.1 Overview

8.28.2 Primary Business

8.28.3 Strategy

8.28.4 Developments

8.29 Smith & Nephew

8.29.1 Overview

8.29.2 Primary Business

8.29.3 Strategy

8.29.4 Developments

8.3 Stryker Corporation

8.30.1 Overview

8.30.2 Primary Business

8.30.3 Strategy

8.30.4 Developments

8.31 Surgical Innovations Group Plc

8.31.1 Overview

8.31.2 Primary Business

8.31.3 Strategy

8.31.4 Developments

8.32 Syneron Medical Ltd

8.32.1 Overview

8.32.2 Primary Business

8.32.3 Strategy

8.32.4 Developments

8.33 Synovis Life Technologies Inc

8.33.1 Overview

8.33.2 Primary Business

8.33.3 Strategy

8.33.4 Developments

8.34 Synthes Inc

8.34.1 Overview

8.34.2 Primary Business

8.34.3 Strategy

8.34.4 Developments

8.35 Teleflex Medical

8.35.1 Overview

8.35.2 Primary Business

8.35.3 Strategy

8.35.4 Developments

8.36 Toshiba Medical Systems

8.36.1 Overview

8.36.2 Primary Business

8.36.3 Strategy

8.36.4 Developments

8.37 Zimmer Holdings Inc

8.37.1 Overview

8.37.2 Primary Business

8.37.3 Strategy

8.37.4 Developments



Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

Leave A Reply

Your email address will not be published.